NCT01201954

Brief Summary

Evaluate the effectiveness of the use of a 24% sucrose solution for pain management of preterm infants during endotracheal suctioning.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for phase_2 pain

Timeline
Completed

Started Mar 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2010

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

September 14, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 15, 2010

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2011

Completed
Last Updated

April 26, 2011

Status Verified

September 1, 2010

Enrollment Period

1.1 years

First QC Date

September 14, 2010

Last Update Submit

April 25, 2011

Conditions

Keywords

painsucrosenewbornmechanical ventilation

Outcome Measures

Primary Outcomes (1)

  • clinical pain score

    The tool that will be used is PIPP = Premature Infant Pain Profile. This avaliation begins prior to suctioning until 30 seconds after suctioning. Each infant will be avaliated 2 times (with sucrose and with placebo). The 2 avaliations in the same day.

    within the first twelve hours after clinical stabilization, the PIPP will be done.

Study Arms (2)

sucrose

ACTIVE COMPARATOR

0,5 ml/kg of sucrose administered 2 minutes prior the procedure

Drug: sucrose

sterile water

PLACEBO COMPARATOR

0,5 ml/kg of sterile water administered 2 minutes prior the procedure

Drug: sucrose

Interventions

oral sucrose solution, 24%, 0,5 ml/kg, 2 minutes before start the suctioning sterile water, 0,5 ml/kg, 2 minutes before start the suctioning

Also known as: sugar
sterile watersucrose

Eligibility Criteria

AgeUp to 36 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • preterm infants
  • over 12 hours of life
  • intubated
  • clinically stable
  • without use of analgesics or sedatives

You may not qualify if:

  • preterms with congenital malformations
  • preterms with genetic syndromes
  • preterms with Apgar score at 5´\<7
  • preterms with meningitis
  • preterms with diagnosed of necrotizing enterocolitis Ouvir Ler foneticamente

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Agamenon Magalhães, Hospital Barão de Lucena

Recife, Pernambuco, Brazil

Location

MeSH Terms

Conditions

Pain

Interventions

SucroseSugars

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

DisaccharidesOligosaccharidesPolysaccharidesCarbohydrates

Study Officials

  • Rita A Almeida, postgraduate

    Universidade Federal de Pernambuco

    PRINCIPAL INVESTIGATOR
  • Sônia B Coutinho, Dr.

    Universidade Federal de Pernambuco

    STUDY DIRECTOR
  • Pedro I Lira, Dr.

    Universidade Federal de Pernambuco

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 14, 2010

First Posted

September 15, 2010

Study Start

March 1, 2010

Primary Completion

April 1, 2011

Study Completion

April 1, 2011

Last Updated

April 26, 2011

Record last verified: 2010-09

Locations